Drug intelligence / Profile preview

Biyunsha Yiganling Granules

Development stage
Unknown
Lead developer
Xian CP
Administration
Oral
01

Overview

Biyunsha Yiganling Granules (also known as Biyunsha Yigan Granules or 碧云砂乙肝颗粒) is an approved traditional Chinese medicine (TCM) developed by the Xi'an Municipal Hospital of Traditional Chinese Medicine and manufactured by Xian Zhengda Pharmaceutical. It is formulated as oral granules and is indicated for the treatment of acute and chronic hepatitis, hepatitis B, early-stage liver cirrhosis, and hepatosplenomegaly. The formulation is composed of multiple herbal ingredients, including *Hedyotis diffusa* (白花蛇舌草), *Rubia cordifolia* (茜草), *Isatis tinctoria* (板蓝根), *Reynoutria japonica* (虎杖), Indigo Naturalis (青黛), green tea (绿茶), *Lithospermum erythrorhizon* (紫草), *Smilax glabra* (土茯苓), *Citrus medica* var. *sarcodactylis* (佛手), *Crataegus pinnatifida* (山楂), *Galli Gigeriae Endothelium Corneum* (鸡内金), silkworm excrement (蚕砂), *Salvia miltiorrhiza* (丹参), *Paris polyphylla* (重楼), *Ganoderma lucidum* (灵芝), *Ophiopogon japonicus* (麦冬), *Schisandra chinensis* (五味子), *Paeonia lactiflora* (白芍), and alum (白矾). It functions by clearing heat, detoxifying, regulating qi, promoting blood circulation, and strengthening the spleen.

Brand names
碧云砂
Other names
Biyunsha Yigan GranulesBiyunsha Yiganling碧云砂乙肝颗粒碧云砂乙肝灵碧云砂乙肝灵颗粒鼻炎沙益肝灵颗粒

Beyond the preview

Go deeper on Biyunsha Yiganling Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biyunsha Yiganling Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call